Pharma
The collaboration comes weeks after Happify announced a partnership with insurer Anthem on a women's health product.
Florence announced it had raised $80 million in its Series C round in May 2021.
The company is leveraging its own portfolio and partner digital assets to directly engage patients at home, virtually or in-person.
The investment will be used for its Asia-Pacific expansion while leveraging Metro's presence.
The consumer genetics company reported full-year revenue came to $272 million, an 11% increase compared with the prior year.
The company seeks to grow its network of pharmacies across the region.
The study will accumulate objective lifestyle data from around 2,000 participants.
They aim to bring down the period and costs for new drug development.
The companies said their long-term goal is to develop and offer more digital health tools "through a multi-partner ecosystem" as well as advocate for reimbursement options.
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.